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ORIGINAL ARTICLE 
Evaluation of strontium-containing 
hydroxyapatite as bone substitute in sheep 
tibiae. 
 
With the advancement of research in biomaterials, it has been suggested 
that the best osteoconductivity of hydroxyapatite would be achieved if its 
crystal were closer to the structure, size and morphology of biological 
apatite, that is why nano-hydroxyapatite (nano-HA) is of great importance. 
current interest. Strontium ions are known to reduce bone resorption, 
induce osteoblastic activity and stimulate bone formation. The aim of this 
study was to evaluate biocompatibility and osteoconduction in surgical 
defects filled with nano-hydroxyapatite microspheres containing 1% 
strontium (nano-SrHA), stoichiometric nano-HA microspheres (nano-HA) 
compared to the clot (control) . Four Santa Inês sheep, weighing an 
average of 32 kg, were anesthetized and submitted to three 2 mm 
diameter perforations in the medial face of the tibia. The surgical defects 
were filled with blood clot, microspheres of Sr-HA 1% and microspheres of 
HA. After 30 days the samples were drawn (6 mm), decalcified, processed 
for inclusion in paraffin and stained with hematoxylin and eosin (HE) for 
histological evaluation with light microscopy. All groups revealed bone 
neoformation from the periphery to the center of the defect, with the 
nano-SrHA group being less intense among those studied. Presence of a 
discrete mononuclear inflammatory infiltrate in all experimental groups. 
Giant foreign body cells were only observed in the HA group. Areas of bone 
neoformation were observed in close contact with both biomaterials. 
According to the results obtained, microspheres of HA and SrHA 1% are 
biocompatible and have osteoconductive properties. 
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Avaliação da hidroxiapatita contendo estrôncio como 
substituto ósseo em tíbias de ovelhas. 
 
Com o avanço das pesquisas em biomateriais, tem sido sugerido que a melhor 
osteocondutividade da hidroxiapatita seria alcançada se o seu cristal estivesse mais 
próximo da estrutura, tamanho e morfologia da apatita biológica, por isso a nano-
hidroxiapatita (nano-HA) é de grande interesse atual. Os íons estrôncio são 
conhecidos por reduzir a reabsorção óssea, induzir a atividade osteoblástica e 
estimular a formação óssea. O objetivo deste estudo foi avaliar a biocompatibilidade 
e a osteocondução em defeitos cirúrgicos preenchidos com microesferas de nano-
hidroxiapatita contendo estrôncio a 1% (nano-SrHA), microesferas de nano-HA 
estequiométrica (nano-HA) em comparação ao coágulo (controle). Quatro ovelhas 
Santa Inês, pesando em média 32 kg, foram anestesiadas e submetidas a três 
perfurações de 2 mm de diâmetro na face medial da tíbia. Os defeitos cirúrgicos foram 
preenchidos com coágulo sanguíneo, microesferas de Sr-HA 1% e microesferas de 
HA. Após 30 dias as amostras foram trefinadas (6 mm), descalcificadas, processadas 
para inclusão em parafina e coradas com hematoxilina e eosina (HE) para avaliação 
histológica com microscopia de luz. Todos os grupos revelaram neoformação óssea 
da periferia para o centro do defeito, sendo o grupo nano-SrHA com menor intensidade 
dentre os estudados. Presença de discreto infiltrado inflamatório mononuclear em 
todos os grupos experimentais. Células gigantes do tipo corpo estranho só foram 
observadas no grupo da HA. Áreas de neoformação óssea foram observadas em 
íntimo contato com ambos os biomateriais. De acordo com os resultados obtidos, 
microesferas de HA e SrHA 1% são biocompatíveis e apresentam propriedade de 
osteocondução. 
 
Palavras-chave: Estrôncio. Durapatita. Ovinos. 
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INTRODUCTION 
 
Localized bone defects can occur as a result of infections, pathological processes, 
congenital injuries, traumatic injuries or even due to tooth extractions and generally 
interfere with the installation of implants and prosthetic rehabilitation. In recent years, 
with the objective of restoring and preserving the alveolar bone morphology, new 
materials and techniques have been the target of research aimed at providing the 
development of a set of procedures and biomaterials that optimize the performance of 
this rehabilitation 10,12 . 
 
Bone grafts are classified according to their origin, as autogenous, allogeneic, 
xenogenous and synthetic or alloplastic. The limitations and difficulties existing to 
obtain autogenous bone grafts, such as post-operative patient discomfort, morbidity of 
the donor site, limitation of the amount of graft, ethical and religious issues, and the 
possibility of transmitting diseases from allogeneic and xenogenous grafts keeps them 
stimulated researchers to develop synthetic biomaterials, to assist in the regeneration 
of lost bone tissue 24 . 
 
Calcium phosphates have been studied as materials used in bone repair for the past 
80 years. Of the compounds based on calcium phosphate, the most extensively 
investigated are hydroxyapatite (HA) and tricalcium phosphate. HA has been widely 
used as an important bone substitute and is distinguished from other calcium 
phosphate-based ceramics because it is similar to the inorganic portion of bone tissue, 
biocompatible, mechanically resistant, bioactive, non-toxic, radiopaque, allowing 
periodic monitoring through imaging tests, cause little tissue reaction and not be 
antigenic or carcinogenic, in addition to having a great capacity for protein adsorption 
on its surface 15. The synthetic HA generally used is in the form of coarse particles, 
which have a size and shape of the crystal quite different from the morphology of the 
biological bone apatites 18 . It has been suggested that the best osteoconductivity of 
AH would be achieved if its crystal were closer to the structure, size and morphology 
of biological apatite 8,16,19 . The high stability and flexibility of this apatite structure, 
allows the wide variety of possible cationic and anionic substitutions, thus having the 
presence of a number of foreign ions associated with biological apatites 18 . Strontium 
(Sr) is present in the mineral phase of bones, especially in regions with greater 
metabolic function 2; its content in the new compact bone is three to four times higher 
than that of an old compact bone, and approximately 2.5 times higher in the new 
cancellous bone than in the oldest 11 . As it increases the activity of osteoblasts and 
decreases the activity of osteoclasts, Sr has an anti-resorptive and bone-forming 
effect in vitro 3 . Calcium phosphate ceramics containing Sr have been shown to 
increase the proliferation and differentiation of osteoblasts in vitro 23 . A previous study 
revealed in vivo an increase in the thickness of the bone layer formed at the bone-
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cement interface and a better osseointegration of SrHA cement, compared to pure HA 
cement 20. The aim of this study was to perform a subjective histological evaluation of 
bone repair in sheep tibias 30 days after implantation of microspheres of nano-
hydroxyapatite (nano-HA) and nano-HA containing 1% strontium (nano-SrHA) in 
comparison clot (control). 
 
 
METHODOLOGY 
 
Four Santa Inês ewes of both genders weighing between 30 and 55 kg and deprived 
of food 24 hours before the surgical procedure were used in this research. The animals 
were previously weighed and operated under general anesthesia, and received as 
preanesthetic medication acepromazine (0.1 mg.kg-1) IV, diazepam (0.2 mg.kg-1) IV 
and morphine (0.4 mg.kg-1) IM. Induction was performed with propofol (4 mg.kg-1) IV 
and diazepam (0.1 mg.kg-1) IV (dose effect), and anesthetic maintenance with 
isoflurane in the appropriate concentration so that autonomic responses did not occur. 
 
After performing the trichotomy and degerming on the medial face of the tibia, the 
animals were installed on the operating table in lateral decubitus. Then, an incision of 
approximately 6 cm was made to allow the detachment until exposure of the skeletal 
plane to make three perforations distant 6-8 cm from the 2 mm diameter tibial crest (2 
mm / spear and spherical cutters) SIN - Implant System, São Paulo, SP, Brazil) (Figure 
1A). The bone defects were filled with nano-HA microspheres, clot and nano-SrHA 
microspheres (Figure 1B). The internal and external planes were sutured with Vycril 
3.0 and Nylon 5.0, respectively. The surgical wound was left uncovered and all animals 
received as a postoperative protocol to prevent infections and meloxicam pain control 
at a dose of 0.5 mg.kg-1 for five days and antibiotic enrofloxacin 5 mg.kg-1, before 
surgery and for five days after all surgical procedures. 
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Figure 1- Surgical procedures for implantation and removal of samples. A. Three 2 mm diameter 
perforations; B. Perforations filled with nano-HA, clot and nano SrHA 1%; C. Bone samples removed 
through local drawing; D. Bone block with a perforation filled with biomaterial. 
 
After the experimental period of 30 days, the animals were anesthetized, as previously 
described, and performed: incision, detachment, removal of the samples with a 6 mm 
internal diameter milling cutter (Figure 1C and 1D) followed by planar suture. The 
animals were kept alive and the suture and postoperative protocol adopted was the 
same as the previous surgical time. 
 
The samples obtained from the 4 animals were fixed for 48 hours in 10% formaldehyde 
buffered with pH 7.4, washed in running water for 6 hours, demineralized with the 
Allkimia® bone softener at room temperature, for 48 hours. After the demineralization 
of the blocks, they were dehydrated, cleared and embedded in paraffin. Transverse 
sections with a thickness of 5 µm and stained with hematoxylin and eosin (HE) were 
obtained and analyzed under light microscopy. In the microscopic analysis, the type 
and intensity of the inflammatory process in response to the procedure, the presence 
of connective tissue and newly formed bone in the surgical defect were described 
through subjective analysis. 
 
 
RESULTS 
 
Histological analysis revealed that in the group containing a clot (control) bone 
neoformation was observed from the periphery to the center of the bone defect, 
consisting of large anastomosed bone trabeculae, however, in the central portion of 
the defect, areas of loose connective tissue and rare inflammatory cells were observed. 
(Figure 2A). 
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Figure 2- Photomicrographs of the experimental groups: 
A- Coagulum 
B- Nano-HA 
C- Nano-Sr-HÁ 
 
 
DISCUSSION 
 
The most important aspect during the development of new biomaterials is the 
experimental and clinical trial to assess their biocompatibility 17 . The use of sheep for 
research has increased over time due to similarities with humans in weight, bone and 
joint structure, and bone regeneration 1,13 . It was observed in this study that the sheep 
drilling model proves to be an excellent animal model to assess the biocompatibility of 
bone substitute biomaterials, where in the implantation model (femur), it revealed the 
possibility of implanting up to 8 biomaterials per animal 14 and also by possibility of 
keeping the animals alive after the end of the experiment. 
 
Nano-HA is of current interest due to its biological properties compared to HA, in 
addition to its greater similarity to physiological apatite 8 . Previous studies have shown 
an increase in the motility of osteoblasts exposed to spherical nano-HA particles 25 and 
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an increase in the migration of these cells when exposed to spherical nano-HA 
particles 9 . Nano-HA exhibits excellent adhesion, not only for mineralized and non-
mineralized tissues 22 . Based on these previous studies, the present study adopted 
spheres as the material format. 
 
The present study demonstrated that HA containing 1% Sr is biocompatible, presenting 
newly formed bone in close contact with the biomaterial, but revealed less intensity of 
bone neoformation than nano-HA, results that were not confirmed by a previous study 
that evaluated a cement of HA containing Sr, which showed better osteoconductivity, 
biocompatibility and biodegradability than the free HA cement of Sr. In addition, the 
doses of Sr incorporated in the crystal structure of HA played an active role in 
vitro and in vivo . From the data from the biocompatibility tests, they observed that the 
cement containing 5% Sr was more biocompatible, followed by the HA cement 
containing 10% Sr and finally the Sr 6 free HA cement.. In another study, by these 
same authors, it was also found that HA cement containing 5% Sr achieved greater 
resistance to compression in the analyzed samples (5-10%) 7 . These data indicate 
that there is an ideal dose of Sr to be incorporated into the HA crystal in order to obtain 
better physico-chemical and biocompatibility properties 5 . However, the results of the 
intramuscular implant and the implantation experiments in the rabbit femur show that 
the average dissolution rate of HA cement containing Sr increases with the increase in 
the dose of Sr 6. This can be explained by the fact that an HA containing substitutions 
is considered a calcium deficient HA and, consequently, more soluble and the greater 
the incorporation of the metal the more calcium deficient it becomes, therefore the 
concentration of the incorporated metal is a important control parameter to adjust the 
properties of HA. 
 
An in vitro study evaluated the bioactivity of HA containing Sr in simulated body fluid, 
and its effect on proliferation, cell morphology, alkaline phosphatase and osteopontin 
activity in the culture of osteoprecursor cells in vitro. The HA ceramics containing Sr 
exhibited high bioactivity in simulated body liquid, which was clear by the rapid 
formation of apatite on its surface. The cell culture test indicated that HA containing Sr 
has good biocompatibility in human osteoblasts. Compared to HA, Sr-HA promoted 
adhesion of osteoprecursor cells and cell proliferation, and did not present any 
deleterious effect on the formation of the extracellular matrix and mineralization. It has 
also been shown that the presence of Sr stimulates the differentiation of 
osteoprecursor cells, and increases alkaline phosphatase and expression of 
osteopontin 23. This study concluded that Mr promotes osteoblastic action and 
subsequent bone neoformation. These results different from those obtained can be 
justified by the concentration of the Sr used in this study (1%). However, more research 
is needed for a detailed understanding of the cellular and molecular mechanisms of 
the effects of strontium on bone cells. 
 
Another in vitro study carried out in order to evaluate the osteoblastic and osteoclastic 
response of HA containing Sr in different concentrations, showed that osteoblastic cells 
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cultured in HA, containing Sr grew showing normal morphology, good proliferation and 
increased values of differentiation parameters, at the same time. At the same time, the 
number of osteoclasts was negatively influenced by the presence of Mr. The positive 
effect of the ion on bone cells was particularly evident in the case of HA deposition 
containing relatively high Sr (3-7%), values that significantly increased the activity of 
alkaline phosphatase, osteocalcin, type I collagen and osteoprotegerin / TNF related 
to cytokine receptors, a considerable reduction in osteoclast proliferation has also been 
observed 4. 
 
An in vivo study investigated the bone tissue response of a bone cement of HA 
containing Sr injected into spongy iliac crest bone of rabbits for 1, 3 and 6 months. 
Bone affinity to HA cement containing Sr increased from 73.55% ± 3.50% after 3 
months to 85.15% ± 2.74% after 6 months (p = 0.01) 21 . These results show that the 
HA cement containing Sr is biocompatible and osteoconductive, confirming the data 
obtained in this study despite our experimental period having been only 30 days. In 
another in vivo study , osseointegration in cancellous bone was achieved with the use 
of HA cement containing Sr in rabbits, which stimulated bone formation and union, the 
fusion of bone with HA cement containing Sr and indicated biocompatibility in 
vivo. Tetracycline staining showed that the mineralization area was in the order: 3 
months - 1 month - 6 months. In the 1st month, the increase in mineralization was due 
to the bone healing process. An additional increase in the mineralization area in 3 
months indicated that HA containing Sr has a stimulating effect on bone formation. The 
mineralization area decreased in 6 months because the healing process was 
concluded with bone remodeling 20 . Among all the studies analyzed, it was observed 
that HA containing Sr is biocompatible depending on the concentration of Sr and the 
period of the experiment. 
 
 
CONCLUSION 
 
According to the results obtained, the microspheres of HA and SrHA 1% can be 
considered biocompatible and with osteoconductive potential and can be indicated as 
bone substitutes. 
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